Avin Drugs Private Limited - Company Profile

It is a pharma private limited company based in Jaipur, Rajasthan, India, established in 2021.
2021 Jaipur, Rajasthan, India Active
Last Updated:
About Avin Drugs Private Limited

Avin Drugs Private Limited, a active private limited company, was established on 12 April 2021 in Jaipur, Rajasthan, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24296RJ2021PTC074513. Registered under ROC Roc Jaipur. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.12 M.

Its leadership includes Ashish Mathur (Director), Sunita Mathur (Director), Yash Wardhan Jain (Director). Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 94/28 And 29 Kumbha Marg Pratap Nagar Sanganer, Jaipur, Rajasthan, 302033.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24296RJ2021PTC074513

  • Registration Number

    074513

  • Incorporation Date

    12 April 2021

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.12 M

  • ROC Code

    Roc Jaipur

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.12 M
  • Company Age 4 Year, 10 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** 55.60%
  • Profit Growth **** 89.41%
  • Ebitda **** 14507.12%
  • Net Worth 3639.58%
  • Total Assets -5.87%
Company report

Avin Drugs Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Avin Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Avin Drugs Private Limited?
Current Directors
Name Designation Appointment Date Status
Ashish Mathur Director 12 Apr 2021 Current
Sunita Mathur Director 12 Apr 2021 Current
Yash Wardhan Jain Director 01 Mar 2022 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Avin Drugs.

Avin Drugs Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 55.6% increase. The company also saw a substantial improvement in profitability, with a 89.41% increase in profit. The company's net worth Soared by an impressive increase of 3639.58%.

Avin Drugs revenue growth over time
Avin Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
55.60%
*******
*******
*******
*******
Revenue from Operations
*******
55.60%
*******
*******
*******
*******
Total Assets
*******
-5.87%
*******
*******
*******
*******
Profit or Loss
*******
89.41%
*******
*******
*******
*******
Net Worth
*******
3639.58%
*******
*******
*******
*******
EBITDA
*******
14507.12%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Avin Drugs?

Unlock access to Avin Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Avin Drugs?

Avin Drugs has a workforce of 0 employees as of Mar 25, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Avin Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Avin Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Avin Drugs
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Avin Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Avin Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Jaipur. was documented.

  • Director Appointment

    Yash Wardhan Jain was appointed as a Director was appointed as a Director on 01 Mar 2022 & has been associated with this company since 4 years . was recorded as a recent event.

  • Director Appointment

    Progress on Ashish Mathur was appointed as a Director was appointed as a Director on 12 Apr 2021 & has been associated with this company since 4 years 10 months . was documented.

  • Director Appointment

    Progress on Sunita Mathur was appointed as a Director was appointed as a Director on 12 Apr 2021 & has been associated with this company since 4 years 10 months . was documented.

  • Company Incorporation

    The activity Avin Drugs Private Limited was registered on 12 Apr 2021 with Roc Jaipur & aged 4 years 10 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Avin Drugs Private Limited?

The CIN of Avin Drugs Private Limited is U24296RJ2021PTC074513.

Where is Avin Drugs Private Limited headquartered?

Avin Drugs Private Limited is headquartered at 94/28 And 29 Kumbha Marg Pratap Nagar Sanganer, Jaipur, Rajasthan, 302033.

When was Avin Drugs Private Limited incorporated?

Avin Drugs Private Limited was incorporated on 12 April 2021.

Who are the current directors of Avin Drugs Private Limited?

The current directors of Avin Drugs Private Limited are

What is the primary industry of Avin Drugs Private Limited?

The primary industry of Avin Drugs Private Limited is Trade.

Is Avin Drugs Private Limited a listed company?

Avin Drugs Private Limited is unlisted.

What is the capital structure of Avin Drugs Private Limited?

The authorized capital of Avin Drugs Private Limited is ₹1.00 M, and the paid-up capital is ₹0.12 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available